Early pathogenesis of spinal and bulbar muscular atrophy uncovered by human iPSC-derived motor neurons highlights pathogenic neuropeptides as therapeutic targets
Authors:
- Kazunari OnoderaKOKazunari Onodera
- Yuichi RikuYRYuichi Riku
- Daisuke ShimojoDSDaisuke Shimojo
- Akinobu OtaAOAkinobu Ota
- Muhammad Irfanur RashidMRMuhammad Irfanur Rashid
- Rina OkadaRORina Okada
- Shinichi YamaguchiSYShinichi Yamaguchi
- Yoshitaka HosokawaYHYoshitaka Hosokawa
- Mari YoshidaMYMari Yoshida
- Yasushi IwasakiYasushi Iwasaki
- Manabu DoyuMDManabu Doyu
- Gen SobueGSGen Sobue
Preprint
Abstract
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by the expansion of the polyglutamine tract in the androgen receptor (AR). Motor neurons (MNs) derived from patient-specific induced pluripotent stem cells (iPSCs) robustly recapitulated early SBMA phenotypes driven by endogenous mutant AR in the absence of testosterone (dihydrotestosterone) and detectable mutant AR aggregation. Notably, endoplasmic reticulum stress markedly exacerbated SBMA pathology. Cross-species integrative analyses of patient-derived neurons and spinal cords of transgenic mouse models revealed high expression of multiple disease-associated neuropeptides, including urotensin II (UTS2), in patient spinal MNs that was correlated with disease onset and progression in iPSC-derived MNs. Downstream signaling analyses of these neuropeptides revealed convergent molecular pathways whose pharmacological inhibition rescued cellular phenotypes. Together, these results establish a human disease model harboring endogenous mutant AR that closely reproduces early SBMA pathology and provides molecular leads for elucidating disease mechanisms and biomarkers and developing therapeutic targets.Keywords
Funding Information
- Japan SBMA Association
- Hori Science and Arts Foundation